News
Johnson & Johnson withdraws 300 stents from market
Gerald Hurowitz, M.D.Published 14 January 20051 min read
Key points
- Johnson & Johnson on Thursday said it has voluntarily withdrawn 300 of its Cypher stents from the US market after determining that the coating on six of the devices did not meet specifications.
- The Cypher stent is a tiny wire mesh tubular device that props open surgically cleared arteries.
- "There is no safety issue," said company spokeswoman Terry Miller.
- It is coated with a drug that prevents the arteries from reclogging with scar tissue.
Johnson & Johnson on Thursday said it has voluntarily withdrawn 300 of its Cypher stents from the US market after determining that the coating on six of the devices did not meet specifications.
The Cypher stent is a tiny wire mesh tubular device that props open surgically cleared arteries. It is coated with a drug that prevents the arteries from reclogging with scar tissue.
"There is no safety issue," said company spokeswoman Terry Miller. "We are committed to quality and are being overcautious."
Written and revised by
Gerald Hurowitz, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
